It’s not easy to get depression-detecting AI through the FDA

Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Instead, a mental health startup shut down and open-sourced its tech. Instead, a mental health startup shut down and open-sourced its tech. Posts from this author will be added to your daily email digest and your homepage feed. Posts from this author will be added to your daily email digest and your homepage feed. For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person’s speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio. Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine. Instead of focusing on what someone is saying, Kintsugi’s software analyzes